Publications
5808 Results
- Journal / Conference
- International Journal of Radiation Oncology, Biology & Physics 84(3):suppl., p S156; ASTRO 2012 Annual Meeting, oral;
- Year
- 2012
- Research Committee(s)
- Lung
- Study Number(s)
- S0533
Initial cooperative group experience of bevacizumab (BEV) plus concomitant chemoradiotherapy (CRT) in patients with inoperable locally advanced stage III non-small cell lung cancer (LA-NSCLC): preliminary results of S0533
- Journal / Conference
- Blood 120(6):1210-1217
- Year
- 2012
- Research Committee(s)
- Lymphoma
- PMID
- PMID22734071
- PMC
- PMC3418716
- Study Number(s)
- S0515
A phase II trial of R-CHOP plus bevacizumab for patients with newly diagnosed diffuse large b-cell non-hodgkin lymphoma: SWOG 0515
- Journal / Conference
- Contemporary Clinical Trials 33(6):1117-1123;
- Year
- 2012
- Research Committee(s)
- Breast
- PMID
- PMID2298189
- PMC
- PMC3486702
- Study Number(s)
- S1007
The value of comparative effectiveness research: projected return on investment of the RxPONDER trial (SWOG S1007)
- Journal / Conference
- New England Journal of Medicine 367(10):895-903
- Year
- 2012
- Research Committee(s)
- Genitourinary
- PMID
- PMID22931259
- PMC
- PMC3521033
- Study Number(s)
- JPR7
Intermittent androgen suppression for rising PSA levels after radiotherapy
- Journal / Conference
- Lancet Oncology 13(7):734-742
- Year
- 2012
- Research Committee(s)
- Breast
- PMID
- PMID22704583
- PMC
- PMC4970583
Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomized trial
- Journal / Conference
- PLoS ONE 7(11):e48787;
- Year
- 2012
- Research Committee(s)
- Melanoma
- PMID
- PMID23226204
- PMC
- PMC3511501
- Study Number(s)
- S0512
Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512
- Journal / Conference
- Journal of Clinical Oncology 30:(suppl 30; abstr 1); ASCO Markers in Cancer Annual Mtg, accepted, oral (Oct 11-13, 2012 Hollywood, FL);
- Year
- 2012
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S0421
Circulating tumor cell (CTC) counts and CTC telomerase activity (TA) are prognostic of overall survival (OS) in SWOG S0421 - docetaxel with or without atrasentan for metastatic castration resistant prostate cancer (mCRPC)
- Journal / Conference
- Cancer Research 72(24 suppl):570S abst. OT2-2-04; San Antonio Breast Cancer Symposium, poster presentation - ongoing trials, (12/4-8/2012, San Antonio, TX);
- Year
- 2012
- Research Committee(s)
- Breast
- Study Number(s)
- S1207
A phase III randomized, placebo-controlled cllinical trial evaluating the use of adjuvant endocrine therapy +/- one year of everolimus in patients with high-risk, hormone receptor-(HR) positive and Her2-neu negative breast cancer: SWOG/NSABP S1207
- Journal / Conference
- Society of Integrative Oncology Annual Meeting (Oct 8-10, 2012, Albuquerque, NM), oral ;
- Year
- 2012
- Research Committee(s)
- Symptom Management and Survivorship
- Study Number(s)
- S1200
Methods for standardizing true and sham acupuncture in a multicenter randomized trial to reduce joint symptoms related to aromatase inhibitors in women with early stage breast cancer (SWOG 1200)
- Journal / Conference
- The Clinical Neuropsychologist 26(5):751-768
- Year
- 2012
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID22651854
- PMC
- PMC23064404
- Study Number(s)
- S0000A